Literature DB >> 9828116

Protein tyrosine phosphatase-eta expression is upregulated by the PKA-dependent and is downregulated by the PKC-dependent pathways in thyroid cells.

M L Martelli1, F Trapasso, P Bruni, M T Berlingieri, C Battaglia, M T Vento, B Belletti, R Iuliano, M Santoro, G Viglietto, A Fusco.   

Abstract

We have recently reported the isolation of a rat cDNA encoding a receptor-type tyrosine phosphatase, which appears to be a marker of thyroid differentiation. To elucidate the molecular mechanisms underlying r-PTPeta expression in normal thyroid cells both in vitro and in vivo, we investigated the regulation of r-PTPeta expression in cultured thyrocytes (the rat cell line PC Cl 3) and in an animal model of TSH-dependent thyroid goitrogenesis. In vitro studies showed that mRNA expression of r-PTPeta in thyroid cells is induced in a time- and dose-dependent manner by the activation of growth- and differentiation-linked PKA pathways (TSH and forskolin), whereas it is down-regulated by the activation of the proliferative dedifferentiating PKC-dependent transduction pathway (TPA). However, the regulation of r-PTPeta expression by TSH and TPA, respectively, is observed only in normal thyroid cells, but is lost in transformed thyroid cells. In vivo studies with thiouracil-fed rats demonstrated that increased serum levels of TSH up-regulated r-PTPeta mRNA expression in parallel with the stimulation of thyroid growth and function. The reduction of blood TSH levels due to iodide refeeding to goitrous rats determined a marked down-regulation of r-PTPeta expression, in parallel with involution of thyroid hyperplasia. Taken together these results demonstrate that the phosphatase r-PTPeta is regulated by the two main thyroid regulatory pathways and suggest that it may play an important role in the growth and differentiation of thyroid cells. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9828116     DOI: 10.1006/excr.1998.4257

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1).

Authors:  F Trapasso; R Iuliano; A Boccia; A Stella; R Visconti; P Bruni; G Baldassarre; M Santoro; G Viglietto; A Fusco
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Crystallization and preliminary X-ray diffraction analysis of rat protein tyrosine phosphatase eta.

Authors:  Huita C Matozo; Alessandro S Nascimento; Maria A M Santos; Rodolfo Iuliano; Alfredo Fusco; Igor Polikarpov
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-08-26

3.  Low-resolution structure and fluorescence anisotropy analysis of protein tyrosine phosphatase eta catalytic domain.

Authors:  Huita C Matozo; Maria A M Santos; Mario de Oliveira Neto; Lucas Bleicher; Luís Mauricio T R Lima; Rodolfo Iuliano; Alfredo Fusco; Igor Polikarpov
Journal:  Biophys J       Date:  2007-03-30       Impact factor: 4.033

4.  Density-enhanced phosphatase 1 regulates phosphorylation of tight junction proteins and enhances barrier function of epithelial cells.

Authors:  Jennifer L Sallee; Keith Burridge
Journal:  J Biol Chem       Date:  2009-03-30       Impact factor: 5.157

5.  Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.

Authors:  Chanel E Smart; Marjan E Askarian Amiri; Ania Wronski; Marcel E Dinger; Joanna Crawford; Dmitry A Ovchinnikov; Ana Cristina Vargas; Lynne Reid; Peter T Simpson; Sarah Song; Christiane Wiesner; Juliet D French; Richa K Dave; Leonard da Silva; Amy Purdon; Megan Andrew; John S Mattick; Sunil R Lakhani; Melissa A Brown; Stuart Kellie
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

Review 6.  PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Franziska Briest; Patricia Grabowski
Journal:  Theranostics       Date:  2014-01-29       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.